Fiber Supplementation During and After GLP-1 Receptor Agonists Treatment: A Perspective on Clinical Benefits

Potential Benefits of Fiber Supplementation During and After GLP-1 Treatment

A new review published in The Journal of Nutrition examines the potential benefits of fiber supplementation during and after treatment with glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of medications commonly used to treat obesity and diabetes. The paper highlights the growing need for supportive nutrition strategies as use of GLP-1 medications continues to rise.

The review notes that many patients experience gastrointestinal side effects while taking GLP-1RAs, including constipation and diarrhea. Clinical studies cited in the paper found that fiber supplementation may help improve bowel function and stool consistency. Researchers also note that most Americans do not consume enough dietary fiber, making supplementation a practical option for many individuals.

The paper also discusses challenges that can occur after stopping GLP-1RA treatment. Available evidence suggests that maintaining weight loss and blood sugar control may become more difficult once treatment ends. According to the review, multiple meta-analyses found that fiber supplementation may help support appetite control, healthy blood glucose levels, insulin response, and body weight maintenance after treatment.

The author concludes that fiber supplementation could serve as a low-cost, evidence-based nutrition strategy both during and after GLP-1RA treatment. While more research is still needed, existing evidence supports the potential role of fiber in digestive health, weight management, and metabolic health support.

Key Takeaways

  • GLP-1 medications can cause gastrointestinal side effects such as constipation and diarrhea.
  • Fiber supplementation may help improve bowel regularity and stool consistency.
  • Most Americans do not meet recommended daily fiber intake levels.
  • Fiber supplements may help support appetite control, blood sugar management, and weight maintenance after GLP-1RA treatment.
  • Researchers suggest fiber supplementation could be a practical, low-cost complementary nutrition strategy.

Related Resources

Learn more about dietary fiber.

Read the study.

Explore More

A landmark study examined how beverages sweetened with sugar or low/no calorie sweeteners affect the brain, blood sugar, insulin, digestion, & appetite.
One of the largest investigations of beverage consumption and liver cancer risk finds no link between low/no calorie sweetened beverages and liver cancer.
A global overview of regulatory approvals for low- and no-calorie sweeteners, including a country-by-country comparison of ingredient permissions.
Comprehensive review finds non-nutritive sweeteners support weight management without adverse health effects.
A global overview on the current use, safety assessments, regulatory status, and science for low- and no-calorie sweeteners and rare sugars.
CCC comments on the 2025-2030 DGAs and the critical role of LNCS in helping Americans lower added sugar & calorie consumption.